X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6395) 6395
Newsletter (698) 698
Newspaper Article (368) 368
Magazine Article (74) 74
Book / eBook (8) 8
Book Chapter (7) 7
Dissertation (5) 5
Web Resource (4) 4
Publication (3) 3
Book Review (1) 1
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5709) 5709
male (2965) 2965
diabetes (2888) 2888
female (2677) 2677
diabetic angiopathies - prevention & control (2548) 2548
endocrinology & metabolism (2361) 2361
risk factors (2357) 2357
middle aged (2165) 2165
aged (1701) 1701
diabetes mellitus, type 2 - complications (1377) 1377
type 2 diabetes (1312) 1312
adult (1275) 1275
diabetic angiopathies - epidemiology (1257) 1257
research (1155) 1155
mortality (1099) 1099
diabetic retinopathy (1030) 1030
diabetes mellitus (941) 941
diabetic angiopathies - physiopathology (924) 924
animals (908) 908
mellitus (892) 892
diabetes mellitus, type 2 - drug therapy (890) 890
cardiovascular disease (868) 868
diabetics (838) 838
diabetic angiopathies - etiology (820) 820
care and treatment (782) 782
cardiovascular diseases - prevention & control (745) 745
diabetes mellitus, type 2 - blood (739) 739
hypoglycemic agents - therapeutic use (738) 738
diabetic angiopathies - drug therapy (701) 701
blood glucose - metabolism (672) 672
cardiac & cardiovascular systems (671) 671
diabetic angiopathies - blood (667) 667
hypertension (665) 665
risk (664) 664
prevention (643) 643
prevalence (612) 612
diabetes mellitus, type 2 - physiopathology (611) 611
medical research (595) 595
glucose (588) 588
cardiovascular diseases (585) 585
cardiovascular-disease (585) 585
health aspects (583) 583
blood pressure (582) 582
medicine, general & internal (554) 554
atherosclerosis (545) 545
complications (545) 545
analysis (535) 535
medicine, experimental (520) 520
treatment outcome (517) 517
risk-factors (501) 501
oxidative stress (493) 493
disease (492) 492
medicine & public health (481) 481
cardiovascular diseases - epidemiology (480) 480
coronary-heart-disease (462) 462
diabetes mellitus, type 1 - complications (456) 456
diabetic angiopathies - therapy (453) 453
insulin (447) 447
hyperglycemia (442) 442
complications and side effects (436) 436
diabetic angiopathies - mortality (432) 432
diabetic angiopathies - complications (419) 419
insulin resistance (419) 419
diabetic angiopathies - diagnosis (409) 409
diabetic foot (409) 409
internal medicine (408) 408
diabetes mellitus, type 2 - epidemiology (401) 401
diabetes complications (397) 397
diabetes therapy (387) 387
follow-up studies (386) 386
myocardial-infarction (368) 368
prospective studies (368) 368
rats (362) 362
aged, 80 and over (351) 351
insulin-resistance (350) 350
time factors (349) 349
cholesterol (333) 333
glycated hemoglobin a - analysis (332) 332
peripheral vascular disease (331) 331
adolescent (329) 329
cross-sectional studies (328) 328
body mass index (323) 323
risk assessment (322) 322
glycated hemoglobin a - metabolism (320) 320
cardiovascular diseases - etiology (319) 319
diabetic angiopathies - metabolism (318) 318
cohort studies (310) 310
diabetic angiopathies (310) 310
blood-pressure (307) 307
diabetic nephropathies - prevention & control (307) 307
studies (306) 306
association (305) 305
insulin - therapeutic use (301) 301
type 1 diabetes (301) 301
prognosis (294) 294
diabetes mellitus, type 2 - therapy (291) 291
antihypertensive agents - therapeutic use (290) 290
obesity (290) 290
hypertension - drug therapy (289) 289
diabetic angiopathies - pathology (285) 285
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7029) 7029
German (183) 183
French (127) 127
Japanese (100) 100
Spanish (41) 41
Italian (36) 36
Russian (36) 36
Czech (22) 22
Portuguese (21) 21
Polish (20) 20
Chinese (17) 17
Danish (11) 11
Swedish (11) 11
Dutch (9) 9
Hungarian (8) 8
Norwegian (6) 6
Finnish (5) 5
Hebrew (5) 5
Croatian (4) 4
Romanian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ, ISSN 0959-8138, 9/2018, Volume 362, p. k3359
Journal Article
Diabetes care, ISSN 1935-5548, 2009, Volume 32, Issue suppl_2, pp. S314 - S321
Journal Article
PloS one, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55396
The thrombogenic activity of Von Willebrand factor (VWF) is proportional to its molecular size and inversely related to its proteolysis by ADAMTS-13. Oxidation... 
INCREASED PLASMA-LEVELS | LOW-DOSE ASPIRIN | MULTIDISCIPLINARY SCIENCES | FACTOR MULTIMERS | SHEAR-STRESS | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | RISK | COMPLICATIONS | DYSFUNCTION | PRIMARY PREVENTION | Diabetic Angiopathies - metabolism | Immunoassay | Oxidation-Reduction | Electrophoresis, Polyacrylamide Gel | Humans | Middle Aged | Diabetes Mellitus, Type 1 - metabolism | Diabetic Angiopathies - etiology | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 2 - metabolism | ADAMTS13 Protein | Protein Carbonylation - physiology | ADAM Proteins - metabolism | Statistics, Nonparametric | Triglycerides - blood | Cholesterol, HDL - blood | Adult | Italy | Thrombotic Microangiopathies - metabolism | Thrombotic Microangiopathies - etiology | Diabetes Mellitus, Type 2 - complications | von Willebrand Factor - metabolism | Type 2 diabetes | Diabetics | Medical research | Proteolysis | Analysis | Von Willebrand factor | Medicine, Experimental | Diabetic retinopathy | Carbonyl compounds | Oxidative stress | Heart attacks | Amino acids | Cardiovascular disease | Biochemistry | Kinases | Molecular weight | Proteins | Plasma proteins | Blood platelets | Electrophoresis | Oxidation | Metalloproteinase | Drug dosages | Carbonyls | Stroke | Aspirin | Internal medicine | Gel electrophoresis | Complications | Diabetes mellitus | Patients | Disease prevention | Medicine | Diabetes | Health risk assessment | Immunoassays | Geriatrics
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 243, Issue 2, pp. 438 - 448
Abstract Objective The circulating irisin increases energy expenditure and improves insulin resistance in mice and humans. The improvement of insulin... 
Cardiovascular | Irisin | AMPK | Diabetes mellitus | Atherosclerosis | Endothelium | APOPTOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | CHOLESTEROL | PHOSPHORYLATION | NITRIC-OXIDE SYNTHASE | CIRCULATING IRISIN | KINASE-C | CORONARY-ARTERY | PERIPHERAL VASCULAR DISEASE | DYSFUNCTION | CELL | ASSOCIATION | Diabetes Mellitus, Experimental - drug therapy | Apolipoproteins E - deficiency | Human Umbilical Vein Endothelial Cells - metabolism | Apoptosis - drug effects | Atherosclerosis - genetics | Diabetes Mellitus, Experimental - genetics | Endothelium, Vascular - drug effects | Male | Diabetic Angiopathies - physiopathology | RNA Interference | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Diabetic Angiopathies - prevention & control | Proto-Oncogene Proteins c-akt - metabolism | Cytokines - genetics | Cytoprotection | Diabetes Mellitus, Experimental - physiopathology | Atherosclerosis - pathology | Fibronectins - pharmacology | Genetic Predisposition to Disease | Human Umbilical Vein Endothelial Cells - drug effects | Atherosclerosis - physiopathology | Endothelial Cells - metabolism | Plaque, Atherosclerotic | Nitric Oxide Synthase Type III - genetics | Atherosclerosis - metabolism | Mice, Knockout | Nitric Oxide Synthase Type III - antagonists & inhibitors | Macrophages - metabolism | Phenotype | Signal Transduction - drug effects | Endothelium, Vascular - metabolism | Endothelium, Vascular - pathology | Human Umbilical Vein Endothelial Cells - pathology | Oxidative Stress - drug effects | Vasodilation - drug effects | Endothelial Cells - pathology | AMP-Activated Protein Kinases - genetics | AMP-Activated Protein Kinases - metabolism | Phosphorylation | Diabetic Angiopathies - pathology | Transfection | Nitric Oxide Synthase Type III - metabolism | Diabetes Mellitus, Experimental - metabolism | Diabetic Angiopathies - genetics | Diabetic Angiopathies - metabolism | Cytokines - metabolism | AMP-Activated Protein Kinases - antagonists & inhibitors | Mice, Inbred C57BL | Cells, Cultured | Endothelium, Vascular - physiopathology | Animals | Apolipoproteins E - genetics | Diabetes Mellitus, Experimental - pathology | Macrophages - drug effects | Protein Kinase Inhibitors - pharmacology | Atherosclerosis - prevention & control | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Endothelial Cells - drug effects | Insulin resistance | Diabetes | Apolipoproteins
Journal Article
Journal of diabetes and its complications, ISSN 1056-8727, 2016, Volume 30, Issue 4, pp. 738 - 745
Abstract Background Vascular complications are the leading cause of morbidity and mortality among patients with type 1 and type 2 diabetes mellitus. These... 
Endocrinology & Metabolism | vascular complications | hypercoagulability | inflammation | endothelial dysfunction | Diabetes mellitus | FACTOR-VIII | MARKERS | MICROVASCULAR COMPLICATIONS | VON-WILLEBRAND-FACTOR | URINARY ALBUMIN EXCRETION | VONWILLEBRAND-FACTOR | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | ASSOCIATION | D-DIMER | Vasculitis - metabolism | Oxidative Stress | Vasculitis - physiopathology | Humans | Diabetes Mellitus, Type 1 - metabolism | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 2 - metabolism | Thrombophilia - complications | Vasculitis - complications | Vasculitis - immunology | Thrombophilia - immunology | Diabetic Angiopathies - physiopathology | Diabetes Mellitus, Type 2 - immunology | Diabetic Angiopathies - complications | Diabetes Mellitus, Type 1 - immunology | Diabetes Mellitus, Type 2 - complications | Endothelium, Vascular - immunology | Diabetic Angiopathies - metabolism | Thrombophilia - physiopathology | Diabetes Mellitus, Type 1 - physiopathology | Endothelium, Vascular - physiopathology | Biomarkers - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Endothelium, Vascular - metabolism | Models, Biological | Diabetic Angiopathies - immunology | Thrombophilia - metabolism | Type 2 diabetes | Oxidative stress | Complications and side effects | Inflammation | Index Medicus
Journal Article
Journal Article
Diabetes care, ISSN 1935-5548, 2015, Volume 38, Issue 8, pp. 1536 - 1543
Journal Article
by Wang, D and Luo, P and Wang, Y and Li, W and Wang, C and Sun, D and Zhang, R and Su, T and Ma, X and Zeng, C and Wang, H and Ren, J and Cao, F
Diabetes (New York, N.Y.), ISSN 1939-327X, 2013, Volume 62, Issue 5, pp. 1697 - 1708
Impaired cardiac microvascular function contributes to cardiovascular complications in diabetes. Glucagon-like peptide-1 (GLP-1) exhibits potential... 
OXIDATIVE STRESS | IN-VITRO | GLP-1 | RECEPTOR AGONISTS | GLUCOSE | ENDOTHELIAL-CELLS | DISEASE | KINASE | ENDOCRINOLOGY & METABOLISM | ANGIOTENSIN-II | DYSFUNCTION | Endothelium, Vascular - cytology | Microvessels - physiopathology | AMP-Activated Protein Kinases - metabolism | Diabetic Cardiomyopathies - metabolism | Microvessels - metabolism | Microvessels - pathology | Endothelium, Vascular - drug effects | Male | Diabetic Cardiomyopathies - physiopathology | Cardiotonic Agents - therapeutic use | Diabetic Angiopathies - physiopathology | Diabetic Angiopathies - pathology | Diabetic Cardiomyopathies - prevention & control | Diabetic Angiopathies - prevention & control | Hyperglycemia - physiopathology | Cyclic AMP - metabolism | Heart Ventricles - pathology | Disease Models, Animal | Hypoglycemic Agents - therapeutic use | Diabetic Angiopathies - metabolism | Second Messenger Systems - drug effects | Glucagon-Like Peptide 1 - metabolism | Glucagon-Like Peptide 1 - analogs & derivatives | Cells, Cultured | Microvessels - drug effects | Rats | Random Allocation | Rats, Sprague-Dawley | Animals | Heart Ventricles - physiopathology | Hyperglycemia - blood | Endothelium, Vascular - metabolism | rho GTP-Binding Proteins - metabolism | Venoms - therapeutic use | Diabetic Cardiomyopathies - pathology | Endothelium, Vascular - pathology | Heart Ventricles - metabolism | Oxidative Stress - drug effects | Peptides - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Heart Ventricles - drug effects | Prevention | Type 2 diabetes | Complications and side effects | Glucagon | Physiological aspects | Genetic aspects | Cellular signal transduction | Research | Cardiovascular diseases | Risk factors | Original Research
Journal Article
Diabetes, obesity & metabolism, ISSN 1463-1326, 2017, Volume 20, Issue 2, pp. 344 - 351
Aims To compare the sodium‐glucose‐cotransporter‐2 (SGLT‐2) inhibitor dapagliflozin with dipeptidyl peptidase‐4 (DPP‐4) inhibitors with regard to risk... 
cardiovascular disease | DPP‐4 inhibitor | type 2 diabetes | diabetes complications | hypoglycaemia | dapagliflozin | DPP-4 inhibitor | SEVERE HYPOGLYCEMIA | MONOTHERAPY | HEART-FAILURE | PREVALENCE | COMBINATION | METFORMIN TREATMENT | INSULIN | DRUGS | ENDOCRINOLOGY & METABOLISM | DPP-4 INHIBITORS | OUTCOMES | Diabetic Cardiomyopathies - ethnology | Cardiovascular Diseases - ethnology | Follow-Up Studies | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Male | Risk | Diabetes Mellitus, Type 2 - metabolism | Incidence | Hypoglycemia - prevention & control | Cardiovascular Diseases - complications | Diabetes Mellitus, Type 2 - ethnology | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - epidemiology | Diabetic Cardiomyopathies - prevention & control | Female | Glucosides - therapeutic use | Diabetic Angiopathies - prevention & control | Hypoglycemia - chemically induced | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Hyperglycemia - prevention & control | Sodium-Glucose Transporter 2 - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Diabetic Angiopathies - ethnology | Sweden - epidemiology | Diabetic Cardiomyopathies - epidemiology | Norway - epidemiology | Denmark - epidemiology | Membrane Transport Modulators - therapeutic use | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Membrane Transport Modulators - adverse effects | Type 2 diabetes | Heart | Complications and side effects | Comorbidity | Atrial fibrillation | Glucose | Comparative analysis | Risk factors | Heart attack | Dextrose | Diabetes therapy | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Heart attacks | Peptidase | Mortality | Diabetes mellitus | Hypoglycemia | Patients | Fibrillation | Sodium | Diabetes | Cardiovascular diseases | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Heart diseases | Original
Journal Article